Dr. Tanya B Dorff MD Medical Oncologist

Dr. Tanya Dorff is a medical oncologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Keck Hospital of USC and University of Southern California-Norris Cancer Hospital. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice for 14 years. Dr. Dorff accepts several types of health insurance, listed below. She is one of 15 doctors at Keck Hospital of USC and one of 9 at University of Southern California-Norris Cancer Hospital who specialize in Medical Oncology.

Are you Dr. Dorff? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: Genitourinary

Clinical Interests: Prostatic Neoplasms, Urinary Bladder Neoplasms, Testicular Neoplasms, Kidney Neoplasms, Complementary Therapies, Androgen Receptors

Hospital Affiliation

Keck Hospital of USC
High performing in Cancer

University of Southern California-Norris Cancer Hospital
Ranked #48 in Cancer

Education & Medical Training

Mount Sinai School of Medicine
Residency, Internal Medicine, 2000–2003

University of Southern California/LAC+USC Medical Center
Fellowship, Medical Oncology, 2003–2004

University of Southern California/LAC+USC Medical Center
Fellowship, Hematology, 2004–2005

University of Southern California/LAC+USC Medical Center
Fellowship, Medical Oncology, 2005–2006

David Geffen School of Medicine at UCLA
Class of 2000

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

CA State Medical License
Active through 2015

Publications & Presentations

Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression.
Cheng, C. W.,Adams, G. B.,Perin, L.,Wei, M.,Zhou, X.,Lam, B. S.,Da Sacco, S.,Mirisola, M.,Quinn, D. I.,Dorff, T. B.,Kopchick, J. J.,Longo, V. D.

Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.
Dorff, T. B.,Tsao-Wei, D. D.,Groshen, S.,Boswell, W.,Goldkorn, A.,Xiong, S.,Quinn, D. I.,Pinski, J. K.

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients.
Mitra, A. P.,Skinner, E. C.,Schuckman, A. K.,Quinn, D. I.,Dorff, T. B.,Daneshmand, S.

See all 30 publications

Insurances Accepted

  • BCBS Tennessee Network 5
  • Multiplan PHCS PPO
  • BCBS Blue Card PPO
  • Multiplan PPO
  • PriorityHealth HMO
  • Aetna Choice POS II
  • Blue Shield California PPO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • United Healthcare - Direct Options PPO
  • BCBS California PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO - Kaiser
  • United Healthcare - Direct Choice Plus POS

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Los Angeles, CA See all Medical Oncologists in California

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.